InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by BAILEY MICHAEL P, Chairman & CEO. Director active across 1 companies, notably Aveo Pharmaceuticals, INC.. In total, 2 reports have been published. Total volume traded: €164k. The latest transaction was disclosed on 1 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€82,08815,000 shares@ €5.4726100.0% of flow
Common Stock
SEC:0000899243-21-035140·
Ideal exit: 29 May 2022 (T+270)
€82,08815,000 shares@ €5.472650.0% of flow
Common Stock
SEC:0000899243-21-035140:0·
Ideal exit: 29 May 2022 (T+270)
2 of 2 declarations
About BAILEY MICHAEL P
Michael P. Bailey is the Chairman and CEO of AVEO Pharmaceuticals, Inc. He leads the company in the development of innovative treatments for cancer-related diseases. His leadership is crucial in guiding the company's strategy and ensuring its success in the pharmaceutical market.
